• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis . Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 Sep 28;S1201-9712(20)32154-8.
doi: 10.1016/j.ijid.2020.09.1438. Online ahead of print.
Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation


M Vassallo[SUP] 1 [/SUP], S Manni[SUP] 2 [/SUP], P Pini[SUP] 3 [/SUP], E Blanchouin[SUP] 3 [/SUP], M Ticchioni[SUP] 4 [/SUP], B Seitz-Polski[SUP] 4 [/SUP], A Puchois[SUP] 5 [/SUP], A Sindt[SUP] 5 [/SUP], L Lotte[SUP] 5 [/SUP], P Fauque[SUP] 6 [/SUP], J Durant[SUP] 7 [/SUP]



Affiliations

Abstract

Objectives: A novel beta coronavirus has been identified as responsible for the 2019 coronavirus infection (Covid-19). Clinical presentations range from asymptomatic cases to acute respiratory distress syndrome with fatal outcome. Such a broad spectrum of disease expression calls for an investigation of immune response characteristics.
Methods: We identified subjects admitted for Covid-19 in whom a large panel of immunological markers were measured, including B- and T- and NK-lymphocyte phenotypes, T-lymphocyte subpopulation cells and plasma cytokines. Patients were divided according to symptom severity during hospitalisation, in those with uncomplicated and complicated infection. Differences between groups were analyzed.
Results: Seventeen patients were included (mean age: 83 years; 9 women; mean delay of symptoms onset: 4 days). Six had uncomplicated infection, while 11 developed complicated forms during the hospitalization. CD10 + B lymphocyte levels were inversely correlated with clinical severity (5.8% vs 2.0%, p = 0.04) and CD10+ levels above 3% were independently associated with uncomplicated forms [Odds Ratio 0.04 (CI 0.002-0.795, p = 0.034)]. TNF-alpha, IL-1, Il-6 and Il-8 measurements upon admission differed between patients who died and those who survived (p < 0.01 for all comparisons).
Conclusions: In a population of elderly patients recently infected with Covid-19, CD10 + B cell levels were inversely correlated with clinical severity. Cytokine values upon admission were highly predictive of fatal outcome during hospitalisation. These findings could explain differences in the clinical presentation and allow rapid identification of patients at risk for complications.

Keywords: Clinical severity; Covid-19; Immune response.
 
Back
Top Bottom